This failure of CD8+ T cells to fully differentiate was found to arise in TILN whether tumor Ag was directly presented by invading melanoma cells or cross‐presented by host Ag‐presenting cells (APC), though CD8+ T cells did acquire effector function if Ag recognition occurred in TFLN at the time of tumor challenge. This evidence concerns the gene CD8A and melanoma.